Ardelyx Inc. sell WatchMen
Start price
03.07.24
/
50%
€4.90
Target price
03.07.25
-
Performance (%)
1.94%
Price
17:27
€5.00
Summary
This prediction is currently active. The SELL prediction by WatchMen shows the price for Ardelyx Inc. has slightly increased by 1.94%. This prediction currently runs until 03.07.25. The prediction end date can be changed by WatchMen at any time. WatchMen has 50% into this predictionArdelyx, Inc. is a biopharmaceutical company that focuses on the research, development, and commercialization of innovative medicines aimed at treating kidney and cardiovascular diseases. The company uses a unique approach to drug discovery, developing therapeutics that target ion channels and transporters, which play a critical role in regulating activities in the body. Ardelyx's lead product candidate, tenapanor, is being studied for the treatment of conditions such as hyperphosphatemia in patients with chronic kidney disease, irritable bowel syndrome with constipation, and diverticulosis. The company is listed on the NASDAQ exchange under the ticker symbol ARDX.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Ardelyx Inc. | 1.94% |
| iShares Core DAX® | 0.786% |
| iShares Nasdaq 100 | 2.297% |
| iShares Nikkei 225® | 3.076% |
| iShares S&P 500 | 0.902% |
Comments by WatchMen for this prediction
In the thread Ardelyx Inc. diskutieren
Sell Ardelyx Inc.